Sigachi Peer Comparison

NSE: SIGACHI | BSE: 543389

₹28.34

₹-0.46 (-1.60%)

As on 01-Oct-2026IST

Market cap

₹1,079 Cr

Revenue (TTM)

₹471 Cr

P/E Ratio

42.6

P/B Ratio

Div. Yield

0.4 %

Edit

	Sigachi	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Market cap (₹ Cr)	1,079	33,904	26,327	27,051	26,160
Revenue (₹ Cr)	471	3,564	9,205	1,936	1,462
Net Profit (₹ Cr)	26.31	414.00	-371.81	288.22	387.35
Net Margin (%)	5.52	11.23	-3.93	14.79	26.01
RoE (%)	3.83	8.38	-3.85	29.77	25.18
Price to Earnings	42.58	82.89	--	93.86	67.73
Price-To-Book	2.04	6.73	3.29	20.15	15.16

Income Statement (₹ Cr)

	Sigachi	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Operating Revenue	470.86	3,564.00	9,205.28	1,935.80	1,461.80
Total Income	476.17	3,686.00	9,449.59	1,948.58	1,489.25
Total Expenditure	424.70	2,792.00	8,195.15	1,485.56	919.25
EBITDA	46.16	772.00	1,010.13	450.24	542.56
Depreciation	17.27	226.00	857.51	50.83	37.68
EBIT	28.89	546.00	152.62	399.41	504.88
Interest	13.61	217.00	342.73	40.84	3.77
Other Income	5.31	122.00	244.31	12.78	27.45
Exceptional Items	2.79	12.00	-216.88	0.00	0.00
Profit before Tax	23.38	463.00	-162.68	371.35	528.56
Provision for Tax	-2.92	49.00	209.13	83.14	141.21
Profit after Tax	26.31	414.00	-371.81	288.22	387.35

	Sigachi	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Shareholder's Funds	521.72	4,940.00	8,162.62	1,288.82	1,653.56
Minority Interest	-0.95	-5.00	0.00	0.00	-1.13
Non-Current Liabilities	41.82	1,712.00	5,044.14	202.03	42.40
Current Liabilities	270.47	1,622.00	4,758.28	835.87	230.82
Total Liabilities	841.17	8,578.00	17,723.32	2,326.71	1,983.96

	Sigachi	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Non-Current Assets	326.41	5,343.00	10,211.52	519.60	1,026.85
Current Assets	389.35	2,606.00	7,191.66	1,681.81	881.27
Total Assets	841.17	8,578.00	17,723.32	2,326.71	1,983.96
Total Debt*	135.56	2,125.00	5,495.48	259.37	26.49
Net Current Assets	118.87	984.00	2,433.38	845.94	650.46
Contingent Liabilities	10.44	768.26	95.72	19.09	17.25

	Sigachi	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Cash From Operating Activities	-42.80	390.00	1,652.60	205.05	292.17
Cash Flow from Investing Activities	-5.45	-241.00	-826.03	-409.72	-265.94
Cash from Financing Activities	2.24	-54.00	-38.98	283.07	4.10
Net Cash Inflow / Outflow	-46.01	95.00	787.59	78.39	30.33

	Sigachi	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
ROCE (%)	-10.72	6.79	1.24	29.22	32.42
ROE (%)	3.83	8.38	-3.85	29.77	25.18
ROA (%)	3.12	4.94	-2.21	24.77	21.93
EBIT Margin (%)	6.13	15.32	1.66	20.63	34.54
Net Margin (%)	5.52	11.23	-3.93	14.79	26.01
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Sigachi	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Revenue Growth (%)	-9.58	18.37	0.78	46.65	40.90
EBIT Growth (%)	-66.30	252.26	-70.53	62.13	124.50
Net Profit Growth (%)	160.80	377.85	-1,383.43	89.49	104.15
EPS Growth (%)	-76.12	1,001.33	-484.84	78.60	42.32
Book Value Growth (%)	-13.17	13.47	0.33	144.31	26.03

	Sigachi	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Price / Earnings	54.74	85.08	-84.14	92.42	67.73
Price / Book Value	2.04	6.73	3.29	20.15	15.16
Dividend Yield (%)	0.35	0.00	0.00	0.09	0.08
EV/EBITDA	25.76	45.81	30.16	59.89	47.85
Market Cap (₹ Cr)	649.61	19,071.62	18,108.89	12,753.19	20,944.75

	Sigachi	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Debt to Equity	0.00	0.31	0.53	0.11	0.02
Short term debt to equity ratio	0.26	0.09	0.09	0.05	0.02
Current Ratio	1.44	1.61	1.51	2.01	3.82
Quick Ratio	1.17	1.06	0.87	1.14	2.82
Interest Coverage	2.72	3.13	0.53	10.09	141.16

	Sigachi	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Debtors to sales (%)	47.61	16.50	23.44	26.28	24.80
Asset Turnover	0.56	0.43	0.55	1.66	0.83
Receivable days	155.78	58.75	78.20	40.13	88.98
Inventory Days	64.11	75.82	93.30	60.29	56.04
Payable days	69.59	186.21	226.14	232.47	99.95
Cash Conversion Cycle	150.30	-51.64	-54.64	-132.04	45.07

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.